Authors:
Matsuzaki, A
Ishii, E
Nagatoshi, Y
Eguchi, H
Koga, H
Yanai, F
Inada, H
Nibu, K
Tamai, Y
Akiyoshi, K
Nakayama, H
Hara, T
Take, H
Miyazaki, S
Okamura, J
Citation: A. Matsuzaki et al., Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: Results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group, INT J HEMAT, 73(3), 2001, pp. 369-377
Authors:
Ishii, E
Eguchi, H
Matsuzaki, A
Koga, H
Yanai, F
Kuroda, H
Kawakami, K
Ayukawa, H
Akiyoshi, K
Kamizono, J
Tamai, Y
Kinukawa, N
Okamura, J
Citation: E. Ishii et al., Outcome of acute lymphoblastic leukemia in children with AL90 regimen: Impact of response to treatment and sex difference on prognostic factors, MED PED ONC, 37(1), 2001, pp. 10-19
Authors:
Ohga, S
Nomura, A
Takada, H
Ihara, K
Kawakami, K
Yanai, F
Takahata, Y
Tanaka, T
Kasuga, N
Hara, T
Citation: S. Ohga et al., Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection, J INFEC DIS, 183(1), 2001, pp. 1-7
Authors:
Koseki, S
Souri, M
Koga, S
Yamakawa, M
Shitishima, T
Maruyama, Y
Yanai, F
Ichinose, A
Citation: S. Koseki et al., Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation, BLOOD, 97(9), 2001, pp. 2667-2672
Authors:
Koseki, S
Souri, M
Koga, S
Yamakawa, M
Shichishima, T
Maruyama, Y
Yanai, F
Ichinose, A
Citation: S. Koseki et al., Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation (vol 97, pg 2667, 2001), BLOOD, 97(12), 2001, pp. 3712-3712
Authors:
Matsuzaki, A
Eguchi, H
Ikuno, Y
Ayukawa, H
Yanai, F
Ishii, E
Sugimoto, T
Inada, H
Anami, K
Nibu, K
Hara, T
Miyazaki, S
Okamura, J
Citation: A. Matsuzaki et al., Treatment of childhood acute myelogenous leukemia with allogeneic and autologous stem cell transplantation during the first remission: A report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan, PED HEM ONC, 17(8), 2000, pp. 623-634
Authors:
Matsuzaki, A
Okamura, J
Ishii, E
Ikuno, Y
Koga, H
Eguchi, H
Yanai, F
Inada, H
Nibu, K
Hara, T
Take, H
Miyazaki, S
Tasaka, H
Citation: A. Matsuzaki et al., Treatment of standard-risk acute lymphoblastic leukemia in children: The results of protocol AL841 from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan, PED HEM ONC, 16(3), 1999, pp. 187-199
Authors:
Kanai, N
Yanai, F
Hirose, S
Nibu, K
Izuhara, K
Tani, T
Kubota, T
Mitsudome, A
Citation: N. Kanai et al., A G to A transition at the last nucleotide of exon 6 of the gamma c gene (868G -> A) may result in either a splice or missense mutation in patients with X-linked severe combined immunodeficiency (vol 104, pg 36, 1999), HUM GENET, 104(2), 1999, pp. 196-196
Authors:
Kanai, N
Yanai, F
Hirose, S
Nibu, K
Izuhara, K
Tani, T
Kubota, T
Mitsudome, A
Citation: N. Kanai et al., A G to A transition at the last nucleotide of exon 6 of the gamma c gene (868G -> A) may result in either a splice or missense mutation in patients with X-linked severe combined immunodeficiency, HUM GENET, 104(1), 1999, pp. 36-42